smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER
Published November 6, 2024 · Recall initiated: October 2, 2024
Summary
FDA records medical device Class II recall Z-0277-2025, published November 6, 2024 and initiated October 2, 2024. Recalling firm: Smith & Nephew Inc; Status: Ongoing; Reported quantity: 3 units; Lot: UDI/DI 03596010543820, Batch Number 23LM00479. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Complaint received indicating that a package contained a LGN OX CONSTRAINED FEM 3 LT implant instead of a LGN OX CONSTRAINED FEM 4 LT as described on the product label.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Smith & Nephew Inc
- Distributor
- US Distribution to state of Texas and OUS (foreign) to countries of: Spain, France and United Kingdom,.
- Lot
- UDI/DI 03596010543820, Batch Number 23LM00479
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAsmith&nephew LEGION OXINIUM POSTERIOR STABILIZED NONPOROUS FEMORAL COMPONENT, SIZE 5N, RIGHT, NARROW, REFNovember 6, 2024
- FDAsmith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 4 LEFT, REF 71421164; PROSTHESIS,November 6, 2024
- FDAsmith&nephew GENESIS II NONPOROUS POSTERIOR STABILIZED FEMORAL COMPONENT, SIZE 5 LEFT, REF 71421015; UncoatedNovember 6, 2024
- FDAKING LTSD,SIZE 2.5, W/SUCTION PORT NON-STERILE KIT-Inserted into a patient s pharynx through the mouth toNovember 6, 2024
- FDAKING LTSD,SIZE 2, W/SUCTION PORT NON-STERILE KIT-Inserted into a patient s pharynx through the mouth toNovember 6, 2024
- FDAsmith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14June 5, 2024
Questions about this recall
Was smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER recalled?
Yes. FDA published recall Z-0277-2025 on November 6, 2024. Reported hazard: Complaint received indicating that a package contained a LGN OX CONSTRAINED FEM 3 LT implant instead of a LGN OX CONSTRAINED FEM 4 LT as described on the product label.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail